newsfilter
← Latest News
GlobeNewswire·

Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress

– Announced strategic long-term exosome manufacturing collaboration with Lonza – – Initial data readout from exoSTING™ clinical trial expected in Q4 2021; initial data from exoIL-12™ trial in CTCL patients now anticipated in H1 2022 –